PA
OXFD

Perceptive Advisors’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

Perceptive Advisors’s Portfolio OXFD Stock Details OXFD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-500,356
Closed -$6.99M – 164
2017
Q4 		$6.99M Buy
500,356
+35,000
+8% +$513K 0.23% 67
2017
Q3 		$7.82M Buy
465,356
+421,250
+955% +$6.86M 0.3% 58
2017
Q2 		$741K Buy
+44,106
New +$659K 0.04% 100

Other funds holding OXFD

Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
GPGA
Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Perceptive Advisors's OXFD Position: Q1 2018 in Review

Perceptive Advisors sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q1 2018, closing a stake of 500,356 shares — an estimated $6.99M sold.

Perceptive Advisors first reported a position in OXFD in Q2 2017 and held it in 3 quarters. The position peaked at $7.82M in Q3 2017. 74 funds tracked by Wall St. Rank hold OXFD as of Q1 2018.

  • Perceptive Advisors reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q1 2018 after selling out during the quarter.
  • Perceptive Advisors sold 500,356 Oxford Immunotec Global PLC Ordinary Shares shares in Q1 2018, an estimated $6.99M.
  • Perceptive Advisors first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q2 2017 and held it in 3 quarters.
  • Perceptive Advisors's Oxford Immunotec Global PLC Ordinary Shares position peaked at $7.82M in Q3 2017.
  • 74 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q1 2018.

Based on Perceptive Advisors's 13F filing for Q1 2018, filed 15 May 2018.